Pembina Pipeline Corp. is investing over $400 million to expand its Alberta feedstock complex. This expansion is crucial for supplying Dow Inc.'s Path2Zero project, highlighting a significant collaboration between the two companies.

Moody's Corporation has shown solid recent earnings and is expanding into AI-powered analytics and risk solutions, driven by demand for its tools and a recovering bond market. The company, known for its credit ratings and analytics, is also focusing on ESG and climate risk assessments. Its strategy involves integrating traditional ratings expertise with modern analytics and digital delivery, attracting investors looking for exposure to capital markets infrastructure and digital transformation.

A Florida judge has ruled in favor of CVS, Walgreens, and Walmart, dismissing a lawsuit from 16 Florida hospitals that accused the pharmacy chains of contributing to the opioid crisis. The judge found that the hospitals were not directly harmed by the pharmacy chains' alleged efforts to boost opioid sales, but rather indirectly through increased patient care costs. This decision follows a mistrial in late 2025 where jurors could not reach a verdict.

Cboe Global Markets has announced the hiring of Boudewijn Duinstra as Executive Vice President and Chief Risk Officer. Duinstra, with over 30 years of experience in risk management and derivatives, will lead Cboe's global risk management function from its Chicago headquarters and Amsterdam. The announcement comes as Cboe's shares trade at a 52-week high, with the company maintaining a "GREAT" financial health score and an 11-year streak of dividend increases.

Dexcom Inc. President, CEO, and Director Jacob Steven Leach reported a tax-related share withholding, where 1,451 shares were withheld at $71.90 per share to cover tax obligations from restricted stock units. This action was not a sale, and Leach retained 420,359 direct Dexcom shares and 47,296 indirect shares through a family trust. The filing also noted 145,686 unvested restricted stock units vesting between 2027 and 2029.

Jefferies upgraded Generac (GNRC) to Buy with a $302 price target due to accelerating AI-driven data center demand and upcoming significant supply agreements for its Baudouin engines. The upgrade follows Generac's strong Q1 2026 performance, where its C&I segment grew 28% and Adjusted EBITDA beat estimates, fueled by its progress with hyperscale customers and a growing backlog. The article highlights Generac's strategic acquisitions and vertical integration efforts to meet anticipated demand, alongside a projected recovery in its Residential segment.

This article provides comprehensive information on the First Trust S&P 500 Diversified Free Cash Flow ETF (FCFY), including its real-time price, key statistics, performance, and structure. It details the ETF's assets under management, dividend yield, expense ratio, and investment holdings, alongside technical analysis indicators and frequently asked questions for investors. The information aims to help potential investors understand FCFY's profile and make informed decisions.

QCR Holdings, Inc. re-elected four Class III directors for three-year terms at its recent annual stockholders meeting and declared a cash dividend of $0.10 per share. The dividend is payable on July 3, 2026, to shareholders of record as of June 18, 2026. The company has a history of 25 consecutive years of dividend payments and a 67% dividend growth over the past year.

Progressive Corp continues to demonstrate strong underwriting profitability and premium growth, maintaining its position as a key player in the US auto and property insurance market. The company’s business model emphasizes disciplined underwriting, dynamic pricing, and data-driven risk selection, aiming for sustained combined ratios below 96%. This operational strategy, along with investment income, supports its long-term profitability and makes it a significant stock for US investors tracking the financial sector.

Crescent Capital BDC (CCAP) has expanded and extended its Wells Fargo credit facility, increasing its size to $500 million and extending maturity dates. The company also issued senior unsecured notes to refinance existing debt, aiming to reshape its capital structure and potentially lower costs. While a recent analyst rating is a Buy with a $13.00 price target, TipRanks' AI Analyst views CCAP as Neutral due to mixed fundamentals and technicals.